Actavis, authorized generics, and the future of antitrust law
Marc G. Schildkraut
| Year of publication: |
2018
|
|---|---|
| Authors: | Schildkraut, Marc G. |
| Published in: |
Research in law and economics. - Leeds : Emerald Publishing, ISSN 0193-5895, ZDB-ID 444790-6. - Vol. 28.2018, p. 25-88
|
| Subject: | Actavis | antitrust | settlement | patent | generic | Sherm | Kartellrecht | Antitrust law | Patentrecht | Patent law | Generika | Generic drugs | Patent | Wettbewerbspolitik | Competition policy |
| Type of publication: | Article |
|---|---|
| Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
| Language: | English |
| Other identifiers: | 10.1108/S0193-589520180000028002 [DOI] |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10012227528